Drug Profile
Research programme: oral aminoglycosides - Galleon Pharmaceuticals
Alternative Names: Amikacin oral - Galleon Pharmaceuticals; GALL 100; Oral aminoglycosides research programme - Galleon PharmaceuticalsLatest Information Update: 06 Jan 2011
Price :
$50
*
At a glance
- Originator Galleon Pharmaceuticals
- Class
- Mechanism of Action Protein 30S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gram-negative infections
Most Recent Events
- 22 Jun 2005 Preclinical trials in Gram-negative infections in USA (PO)